Table 1.
Study | Study location | Study Design | Sample Size | Type of Plasmodium Species | Malaria detection Method |
---|---|---|---|---|---|
Alemayehu 2020 [31] | Ethiopia | Cross-sectional study | 897 | P. falciparum | RT-PCR |
Aribodor 2009 [56] | Nigeria | Cross-sectional study | 500 | P. falciparum | Thick smear |
Bassey 2015 [57] | Nigeria | Cross-sectional study | 210 | P. falciparum | Thick and thin smears |
Bater 2020 [29] | Uganda | Prospective cohort study | 3841 | NA | RDT |
Biteghe-Bi-Essone 2022 [41] | Gabon | Transversal study | 323 | P. falciparum | RDT, thick blood smear |
Chawla 2007 [46] | India | Observational study | 416 | P. falciparum, P. vivax | Peripheral blood smear |
Datta 2017 [44] | India | Prospective study | 64 | P. falciparum, P. vivax | Peripheral blood smear or ELISA test |
Dombrowski 2018 [34] | Brazil | Observational study | 14,487 | P. falciparum, P. vivax | Thin and thick blood smear |
Dombrowski 2019 [33] | Brazil | Cohort study | 4291 | P. falciparum, P. vivax | Peripheral blood thin and thick blood smear |
Dombrowski 2021 [35] | Brazil | Observational cohort study | 329 | P. vivax | Thick and thin peripheral blood smears & and PCR |
Feresu 2015 [50] | Zimbabwe | Secondary data analysis | 3110 | NA | NA |
Gavina 2018 [54] | Colombia | Longitudinal study | 180 | P. falciparum, P. vivax | RT-qPCR, and placental histopathology |
Gaw 2019 [49] | Democratic Republic of the Congo | Cross-sectional study | 34 | P. falciparum | Malaria symptoms and Peripheral blood smear |
Honkpéhèdji 2021 [42] | Gabon | Cohort study | 678 | P. falciparum | Thick blood smear |
Hussein 2022 [39] | Ghana | Prospective cohort study | 1323 | P. falciparum | RDT |
Kamga 2024 [36] | Cameroon | Cross-sectional study | 380 | P. falciparum | PCR |
Kumlachew 2018 [32] | Ethiopia | A cross-sectional study | 381 | NA | NA |
Lingani 2022 [55] | Burkina Faso | Cross-sectional study | 600 | P. falciparum | Peripheral blood sample |
Lloyd 2018 [38] | Cameroon | Observational study | 1377 | P. falciparum | Thick and thin blood smears |
Luxemburger 2001 [48] | Thailand | Cohort study | 1495 | P. falciparum, P. vivax | Blood Smear |
Megnekou 2023 [37] | Cameroon | Retrospective case-control study | 134 | P. falciparum | Thick and thin blood smears |
Mikomangwa 2019 [53] | Tanzania | Cross-sectional study | 631 | NA | RDT |
Nekaka 2020 [30] | Uganda | Cross-sectional study | 210 | P. falciparum | Thick and thin peripheral blood smears & and PCR |
Nkwabong 2020 [19] | Cameroon | Cohort study | 3063 | NA | RDT, thick blood smear |
Quanquin 2020 [28] | Uganda | Observational study | 40 | P. falciparum | Placenta biopsies for histological diagnosis with PCR |
Quinn 2021 [40] | Ghana | Cohort study | 1288 | NA | Placental histopathology |
Rijken 2014 [47] | Thailand | Population Cohort Study | 10,264 | P. falciparum, P. vivax | Giemsa stained thick and thin blood films |
Singh 2014 [45] | India | Observational study | 203 | P. falciparum, P. vivax | Thick and thin smear |
Singh 2020 [43] | India | Prospective cohort study | 286 | P. falciparum | Thin and thick blood smear |
Ticconi 2003 [51] | Zimbabwe | Case-control study | 986 | NA | Blood smear |
Weckman 2021 [52] | Malawi | Observational cohort study | 421 | P. falciparum | PCR |
Abbreviations: ELISA: Enzyme-Linked Immunosorbent Assay, NA: Not Available, PCR: Polymerase Chain Reaction, RDT: Rapid Diagnostic Test, RT PCR: Reverse Transcription Polymerase Chain Reaction, RT-qPCR: Reverse Transcription Quantitative Polymerase Chain Reaction.